Kugathasan L, Tsoukas MA, Nardone M, Sridhar VS, et al. Semaglutide and cardiovascular risk in type 1 diabetes: A predictive modelling analysis in a double-blind, randomised, placebo-controlled cross-over trial. Diabetes Obes Metab 2026 Feb 2. doi: 10.1111/dom.70525.
PMID: 41623193